Cypress Wealth Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cypress Wealth Services's NVS Position: Q3 2026 in Review
Cypress Wealth Services reduced its Novartis (NVS) stake by 13% in Q3 2026, selling an estimated $38.4K and leaving 1,695 shares worth $239K. The position accounts for 0.03% of the portfolio, ranked #382.
Cypress Wealth Services first reported a position in NVS in Q4 2020 and has held it in 11 quarters since. The position peaked at $359K in Q4 2025. 839 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Cypress Wealth Services held 1,695 shares of Novartis worth $239K as of Q3 2026.
- Cypress Wealth Services sold 253 Novartis shares in Q3 2026, an estimated $38.4K.
- Novartis made up 0.03% of Cypress Wealth Services's portfolio in Q3 2026, its #382 holding.
- Cypress Wealth Services first reported a position in Novartis in Q4 2020 and has held it in 11 quarters since.
- Cypress Wealth Services's Novartis position peaked at $359K in Q4 2025.
- 839 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Cypress Wealth Services's 13F filing for Q3 2026, filed 21 Oct 2026.